Physiological Regulation of Blood Glucose

Physiological regulation of blood glucose is the essential homeostatic process that maintains blood sugar concentrations within a narrow physiological range to ensure adequate energy supply for the brain and other organs (StatPearls, 2023). This regulation is primarily governed by the endocrine pancreas, where alpha cells secrete glucagon to raise blood glucose and beta cells secrete insulin to lower it (NIH, 2022). Insulin facilitates glucose entry into muscle and adipose cells via GLUT4 transporters and suppresses hepatic glucose output, while glucagon promotes glycogenolysis and gluconeogenesis during fasting states. When these regulatory mechanisms fail, it results in pathological states such as diabetes mellitus, which is characterized by chronic hyperglycemia and long-term damage to the heart, kidneys, and eyes (WHO, 2023). Therapeutic strategies for managing blood glucose involve a diverse array of drugs that target specific molecular components of this regulatory network, such as the insulin receptor, GLP-1 receptor, and SGLT2 transporters. These medications work through various mechanisms, including enhancing insulin sensitivity, stimulating endogenous insulin release, or promoting the excretion of excess glucose through the kidneys (PubMed, 2021). Monitoring this physiological process is critical in clinical practice, utilizing biomarkers like HbA1c and fasting glucose levels to guide treatment and prevent complications.

Other names

Glucose homeostasisBlood sugar regulationGlycemic controlGlucose metabolism

The regulation of blood glucose involves a multi-organ system where insulin promotes glucose uptake and storage while glucagon stimulates glucose release; drugs target these pathways by increasing insulin sensitivity, stimulating insulin secretion, or inhibiting glucose production and reabsorption.